transcription factor inhibitor for Ewing sarcoma/prostate cancer(Altay Therapeutics)

N/A

Report date: 2025/01/26 17:13:19
NME

Base Information

Drug Nametranscription factor inhibitor for Ewing sarcoma/prostate cancer(Altay Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscription factors inhibitors
TargetsTranscription factors
Therapy Area/IndicationsProstatic NeoplasmsSarcoma, Ewing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAltay Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAltay Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsSarcoma, Ewing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A